Correction: BRAFV600E -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

M Herman Chui; Susanne K Kjaer; Kirsten Frederiksen; Charlotte G Hannibal; Tian-Li Wang; Russell Vang; Ie-Ming Shih

doi:10.18632/oncotarget.28001

Correction: BRAFV600E -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

M Herman Chui, Susanne K Kjaer, Kirsten Frederiksen, Charlotte G Hannibal, Tian-Li Wang, Russell Vang, Ie-Ming Shih

Abstract

[This corrects the article DOI: 10.18632/oncotarget.27326.].

Original language	English
Journal	Oncotarget
Volume	12
Issue number	13
Pages (from-to)	1323-1324
Number of pages	2
ISSN	1949-2553
DOIs	https://doi.org/10.18632/oncotarget.28001
Publication status	Published - 22 Jun 2021

Access to Document

10.18632/oncotarget.28001

Cite this

@article{35041b3278764fafa59576951b85951d,

title = "Correction: BRAFV600E -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma",

abstract = "[This corrects the article DOI: 10.18632/oncotarget.27326.].",

author = "Chui, {M Herman} and Kjaer, {Susanne K} and Kirsten Frederiksen and Hannibal, {Charlotte G} and Tian-Li Wang and Russell Vang and Ie-Ming Shih",

note = "Copyright: {\textcopyright} 2021 Chui et al.",

year = "2021",

month = jun,

day = "22",

doi = "10.18632/oncotarget.28001",

language = "English",

volume = "12",

pages = "1323--1324",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "13",

}

TY - JOUR

T1 - Correction

T2 - BRAFV600E -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

AU - Chui, M Herman

AU - Kjaer, Susanne K

AU - Frederiksen, Kirsten

AU - Hannibal, Charlotte G

AU - Wang, Tian-Li

AU - Vang, Russell

AU - Shih, Ie-Ming

PY - 2021/6/22

Y1 - 2021/6/22

N2 - [This corrects the article DOI: 10.18632/oncotarget.27326.].

AB - [This corrects the article DOI: 10.18632/oncotarget.27326.].

U2 - 10.18632/oncotarget.28001

DO - 10.18632/oncotarget.28001

M3 - Comment/debate

C2 - 34194631

SN - 1949-2553

VL - 12

SP - 1323

EP - 1324

JO - Oncotarget

JF - Oncotarget

IS - 13

ER -

Correction: BRAFV600E -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

Abstract

Access to Document

Fingerprint

Cite this